Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis. Patients who routinely see dermatologists or rheumatologists for psoriasis or psoriatic...
Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis. Patients who routinely see dermatologists or rheumatologists for psoriasis or psoriatic...
Contrast-enhanced dual-energy CT improves diagnosis and guided management of suspected inflammatory arthritis of the hand.
Renal issues in seronegative spondylarthritis appear common but were reported inconsistently.
Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis.
Researchers developed a novel ultrasonic implant that shows promise for personalized, efficient, and minimally invasive chronic pain management.
Soumya Chakravarty, MD, PhD, FACP, FACR, senior director, strategic lead rheumatology therapeutic area, Johnson & Johnson Innovative Medicine, highlights the APEX study's findings that Tremfya (guselkumab) is the first IL-23 inhibitor to significantly inhibit structural damage progression in biologic-naïve psoriatic arthritis patients, offering a multi-domain, early treatment option with a consistent safety profile to help preserve long-term function and quality of life.
Contrast-enhanced dual-energy CT improves diagnosis and guided management of suspected inflammatory arthritis of the hand.
Renal issues in seronegative spondylarthritis appear common but were reported inconsistently.
Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with psoriasis or psoriatic arthritis.
Researchers developed a novel ultrasonic implant that shows promise for personalized, efficient, and minimally invasive chronic pain management.
Soumya Chakravarty, MD, PhD, FACP, FACR, senior director, strategic lead rheumatology therapeutic area, Johnson & Johnson Innovative Medicine, highlights the APEX study's findings that Tremfya (guselkumab) is the first IL-23 inhibitor to significantly inhibit structural damage progression in biologic-naïve psoriatic arthritis patients, offering a multi-domain, early treatment option with a consistent safety profile to help preserve long-term function and quality of life.
You ask, she answers! Dr. MedLaw responds to a physician’s question regarding fee-splitting, leading to a discussion of kickbacks and regulatory claims. Physican: I’m expanding my internal medicine practice to include more wellness care, and I want to market that....
Dr. Alex McDonald shares a letter he recently sent to Senator Bill Cassidy expressing urgent concerns regarding HHS leadership and public health integrity. Dear Senator Cassidy, As a family and sports medicine physician and a concerned citizen, I am writing to you...
You ask, she answers! Dr. MedLaw responds to a physician's question regarding how to decrease liability risk for on-call telephone consultations.
This course discusses an evidence-based best practice guidance for assessing and managing patients with psoriatic arthritis.
This course discusses sarcopenia screening in patients with type 2 diabetes that appear to be at increased risk for and may develop cardiovascular disease earlier in life than people with type 2 diabetes alone.
This course discusses a study that elucidated the value of patient-reported outcome measures in real-world psoriatic arthritis management.
Paging laughter: this week’s medical cartoon delivers an infusion of healthcare humor, zero adverse events, and rapid onset of...
Here’s your weekly medical cartoon—a quick dose of humor and insight to brighten your day and reflect the quirks of life in...
Physicians can secure a steady, tax-advantaged retirement income through options like lifetime annuities and QLACs, tailored to their needs and timelines. Preparing for retirement can be daunting for many people, and physicians are no exception. Identifying the...
Physicians should explore retirement planning options and employ a strategy that limits volatility, guards against outliving assets, and preserves buying power.
Generational conflicts in the medical workplace can cause problems, but fostering open dialogue and building inclusivity can improve collaboration and trust.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.